Market forces are aligning with clinical need. Broader investment in AI across healthcare and pharma is producing bigger addressable markets and faster product maturation. Industry reports project robust growth in AI applications for pharmaceutical and medication-management use cases over the coming decade, driven by rising AI adoption, regulatory encouragement of digital tools that improve safety, and an intensified focus on cost-effective chronic disease management. Estimates for adjacent markets — AI in pharma and AI for medication management — show strong CAGR figures and expanding revenue bases, supporting the plausibility of rapid expansion for AI-powered polypharmacy solutions.
1회 조회